Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04205630
Title SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Byondis B.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL


No variant requirements are available.